Project Name,Region,Country,Site ID,Subject ID,Latest Visit (SV) (Source: Rave EDC: BO4),Subject Status (Source: PRIMARY Form),Input files,,,,,,,,,CPMD,,,,,,,,,,,,,,,,,,,,,,SSM,,,,,
,,,,,,,Missing Visits,Missing Page,# Coded terms,# Uncoded Terms,# Open issues in LNR,# Open Issues reported for 3rd party reconciliation in EDRR,Inactivated forms and folders,# eSAE dashboard review for DM,# eSAE dashboard review for safety,Visit status,Page status (Source: (Rave EDC : BO4)),,,,,Queries status (Source:(Rave EDC : BO4)),,,,,,,,Page Action Status (Source: (Rave EDC : BO4)),,,,,,Protocol Deviations (Source:(Rave EDC : BO4)),,PI Signatures (Source: (Rave EDC : BO4)),,,,,
,,,,,,,,,,,,,,,,# Expected Visits (Rave EDC : BO4),# Pages Entered,# Pages with Non-Conformant data,# Total CRFs with queries & Non-Conformant data,# Total CRFs without queries & Non-Conformant data,% Clean Entered CRF,# DM Queries,# Clinical Queries,# Medical Queries,# Site Queries,# Field Monitor Queries,# Coding Queries,# Safety Queries,#Total Queries,# CRFs Require Verification (SDV),# Forms Verified,# CRFs Frozen,# CRFs Not Frozen,# CRFs Locked,# CRFs Unlocked,# PDs Confirmed,# PDs Proposed,# CRFs Signed,CRFs overdue for signs within 45 days of Data entry,CRFs overdue for signs between 45 to 90 days of Data entry,CRFs overdue for signs beyond 90 days of Data entry,Broken Signatures,CRFs Never Signed
Responsible LF for action,,,,,,,,,,,,,,,,,,Site/CRA,,,,DM,CSE/CDD,CDMD/Medical Lead,Site/CRA,CRA,Coder,Safety Team,,CRA,,,DM,,,CD LF,,Investigator,,,,,
Study 17,EMEA,FRA,Site 466,Subject 3544,UNPLANNED VISIT (1),On Trial,,,,,,,,,,14,150,1,,,,0,0,0,2,0,0,0,2,57,80,0,0,0,0,0,0,0,41,65,32,0,138
Study 17,EMEA,FRA,Site 466,Subject 3545,CYCLE 2 DAY 15 (1),On Trial,,,,,,,,,,14,147,0,,,,0,0,0,1,0,0,0,1,54,30,0,0,0,0,0,0,0,54,51,31,0,136
Study 17,EMEA,FRA,Site 466,Subject 3546,CYCLE 2 DAY 1 (1),On Trial,,,,,,,,,,13,154,0,,,,0,0,0,3,0,0,0,3,58,36,0,0,0,0,0,0,2,78,58,0,3,133
Study 17,EMEA,FRA,Site 466,Subject 3547,POST 68GA-NNS309 IMAGING (1),Discontinued,,,,,,,,,,3,46,0,,,,0,0,0,0,0,0,0,0,23,6,0,0,0,0,0,0,0,31,13,0,0,44
Study 17,EMEA,ISR,Site 469,Subject 3565,UNPLANNED VISIT (2),On Trial,,,,,,,,,,3,57,0,,,,0,1,0,0,0,0,0,1,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 17,EMEA,ISR,Site 469,Subject 4744,UNPLANNED RECIST (1),Discontinued,,,,,,,,,,12,141,0,,,,0,1,0,0,0,0,0,1,0,88,0,0,0,0,0,0,128,0,0,0,0,0
Study 17,EMEA,ISR,Site 469,Subject 4745,END OF TREATMENT (1),On Trial,,,,,,,,,,19,295,0,,,,1,1,0,3,0,0,0,5,20,197,0,0,0,0,0,0,236,16,0,0,2,14
Study 17,EMEA,ISR,Site 469,Subject 4746,68GA-NNS309 IMAGING (1),On Trial,,,,,,,,,,2,39,0,,,,0,0,0,0,0,0,0,0,1,26,0,0,0,0,0,0,36,0,0,0,0,0
Study 17,EMEA,ISR,Site 469,Subject 4747,UNPLANNED RECIST (1),Completed,,,,,,,,,,10,166,0,,,,2,5,0,2,0,0,0,9,2,94,0,0,0,0,0,0,137,3,0,0,3,0
Study 17,EMEA,ISR,Site 469,Subject 4748,UNPLANNED RECIST (1),Discontinued,,,,,,,,,,12,136,0,,,,0,2,0,0,0,0,0,2,0,81,0,0,0,0,0,0,127,0,0,0,0,0
Study 17,EMEA,ISR,Site 469,Subject 4749,UNPLANNED VISIT (5),Discontinued,,,,,,,,,,9,166,0,,,,26,1,0,4,0,0,0,31,37,65,0,0,0,0,0,0,103,39,0,0,6,33
Study 17,EMEA,ISR,Site 469,Subject 4750,SCREENING,Screening,,,,,,,,,,0,9,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,7,0,0,0,0,0
Study 17,EMEA,ISR,Site 469,Subject 4751,SCREENING,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,3,6,0,0,1,5
Study 17,EMEA,ESP,Site 7,Subject 14,CYCLE 2 DAY 1 (1),On Trial,,,,,,,,,,12,213,1,,,,0,1,0,1,5,0,0,7,52,125,0,0,0,0,0,0,132,55,0,0,26,29
Study 17,EMEA,ESP,Site 7,Subject 594,END OF TREATMENT (1),On Trial,,,,,,,,,,12,134,0,,,,0,1,0,0,4,0,0,5,30,41,0,0,0,0,1,0,38,85,0,0,14,71
Study 17,EMEA,ESP,Site 775,Subject 4752,CYCLE 1 DAY 15 (1),On Trial,,,,,,,,,,9,112,1,,,,22,5,0,5,0,0,0,32,84,19,0,0,0,0,0,0,0,103,1,0,0,104
Study 17,EMEA,CHE,Site 776,Subject 4753,SCREENING,,,,,,,,,,,0,4,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,2,0,0,0,0,0
Study 17,EMEA,CHE,Site 776,Subject 4754,68GA-NNS309 IMAGING (1),Screening,,,,,,,,,,2,50,0,,,,0,0,0,1,0,0,0,1,2,38,0,0,0,0,0,0,41,0,0,0,0,0
Study 17,EMEA,CHE,Site 776,Subject 4755,68GA-NNS309 IMAGING (1),Screening,,,,,,,,,,2,37,0,,,,1,0,0,0,0,0,0,1,0,24,0,0,0,0,0,0,33,0,0,0,0,0
Study 17,AMERICA,CAN,Site 14,Subject 25,UNPLANNED VISIT (11),Discontinued,,,,,,,,,,11,191,0,,,,0,1,0,2,0,0,0,3,1,122,0,0,0,0,1,0,156,1,4,0,5,0
Study 17,AMERICA,CAN,Site 14,Subject 26,UNPLANNED RECIST (1),Discontinued,,,,,,,,,,10,118,0,,,,0,8,0,7,2,0,0,17,20,88,0,0,0,0,0,0,0,15,89,0,0,104
Study 17,AMERICA,CAN,Site 15,Subject 39,CYCLE 1 DAY 8 (1),On Trial,,,,,,,,,,7,83,0,,,,0,1,0,12,0,0,0,13,10,52,0,0,0,0,0,1,0,64,0,0,0,64
Study 17,AMERICA,CAN,Site 15,Subject 40,68GA-NNS309 IMAGING (1),On Trial,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,3,1,0,0,0,0,0,0,0,9,0,0,0,9
Study 17,AMERICA,CAN,Site 16,Subject 55,UNPLANNED VISIT (4),Discontinued,,,,,,,,,,9,164,0,,,,0,9,0,2,0,0,0,11,24,122,0,0,0,0,0,0,139,0,0,0,0,0
Study 17,AMERICA,CAN,Site 16,Subject 56,68GA-NNS309 IMAGING (1),Screen Failure,,,,,,,,,,2,47,0,,,,0,0,0,0,0,0,0,0,1,28,0,0,0,0,0,0,45,0,0,0,0,0
Study 17,AMERICA,USA,Site 177,Subject 1593,SCREENING,Screening,,,,,,,,,,0,9,0,,,,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,7,0,0,0,7
Study 17,AMERICA,USA,Site 177,Subject 1594,SCREENING,Screening,,,,,,,,,,0,9,0,,,,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,7,0,0,0,7
Study 17,AMERICA,USA,Site 177,Subject 1595,CYCLE 1 DAY 15 (1),Completed,,,,,,,,,,7,95,6,,,,9,0,0,48,1,0,0,58,37,10,0,0,0,0,0,0,0,76,0,0,0,76
Study 17,AMERICA,USA,Site 177,Subject 1596,SCREENING,Screen Failure,,,,,,,,,,0,14,0,,,,0,0,0,6,0,0,0,6,6,0,0,0,0,0,0,0,0,8,0,0,0,8
Study 17,AMERICA,USA,Site 18,Subject 63,SCREENING,Screen Failure,,,,,,,,,,0,9,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,0,7,0,0,0,7
Study 17,AMERICA,USA,Site 18,Subject 64,SCREENING,Screen Failure,,,,,,,,,,0,9,0,,,,0,0,0,1,0,0,0,1,2,2,0,0,0,0,0,0,0,7,0,0,0,7
Study 17,AMERICA,USA,Site 19,Subject 77,POST 68GA-NNS309 IMAGING (1),On Trial,,,,,,,,,,3,50,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,1,0,1,0
Study 17,AMERICA,USA,Site 19,Subject 78,90 DAYS SAFETY FUP (1),Discontinued,,,,,,,,,,17,184,0,,,,0,0,0,0,0,0,0,0,0,105,0,0,0,0,0,0,162,0,3,0,3,0
Study 17,AMERICA,USA,Site 19,Subject 79,90 DAYS SAFETY FUP (1),On Trial,,,,,,,,,,15,181,0,,,,0,1,0,0,0,0,0,1,0,102,0,0,0,0,0,0,154,0,6,4,6,4
Study 17,AMERICA,USA,Site 19,Subject 80,END OF TREATMENT (1),Completed,,,,,,,,,,14,158,0,,,,0,0,0,0,0,0,0,0,8,82,0,0,0,0,0,0,142,0,1,0,1,0
Study 17,AMERICA,USA,Site 19,Subject 81,POST 68GA-NNS309 IMAGING (1),On Trial,,,,,,,,,,3,51,0,,,,0,0,0,0,0,0,0,0,1,32,0,0,0,0,0,0,44,0,3,0,3,0
Study 17,AMERICA,USA,Site 19,Subject 4756,CYCLE 1 DAY 15 (1),On Trial,,,,,,,,,,8,97,0,,,,2,1,0,0,0,0,0,3,13,47,0,0,0,0,0,0,0,50,42,0,0,92
Study 17,AMERICA,USA,Site 19,Subject 4757,POST 68GA-NNS309 IMAGING (1),On Trial,,,,,,,,,,3,40,0,,,,4,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,38,0,0,0,38
Study 17,AMERICA,USA,Site 325,Subject 2648,SCREENING,,,,,,,,,,,1,11,0,,,,0,0,0,3,0,0,0,3,8,0,0,0,0,0,0,0,0,8,0,0,0,8
Study 17,AMERICA,USA,Site 325,Subject 2649,CYCLE 1 DAY 8 (1),On Trial,,,,,,,,,,7,81,0,,,,16,1,0,7,0,0,0,24,42,1,0,0,0,0,0,0,0,57,0,0,0,57
Study 17,AMERICA,USA,Site 327,Subject 2664,90 DAYS SAFETY FUP (1),On Trial,,,,,,,,,,20,242,0,,,,0,2,0,4,0,0,0,6,5,217,0,0,0,0,0,0,215,7,0,0,2,5
Study 17,AMERICA,USA,Site 327,Subject 2665,CYCLE 2 DAY 15 (1),Discontinued,,,,,,,,,,14,169,1,,,,0,0,0,3,0,0,0,3,1,93,0,0,0,0,0,0,150,3,0,0,3,0
Study 17,AMERICA,USA,Site 327,Subject 2666,CYCLE 3 DAY 2 (1),On Trial,,,,,,,,,,17,183,0,,,,0,3,0,4,0,0,0,7,6,105,0,0,0,0,0,0,139,33,0,0,12,21
Study 17,AMERICA,USA,Site 327,Subject 2667,SCREENING,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,7,0,0,0,0,0
Study 17,AMERICA,USA,Site 327,Subject 3395,SCREENING,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,7,0,0,0,0,0
Study 17,AMERICA,USA,Site 327,Subject 3396,CYCLE 1 DAY 22 (1),Discontinued,,,,,,,,,,9,107,0,,,,9,2,0,0,2,0,0,13,11,51,0,0,0,0,0,0,84,14,0,0,10,4
Study 17,AMERICA,USA,Site 327,Subject 4758,SCREENING,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,7,0,0,0,0,0
Study 17,AMERICA,USA,Site 327,Subject 4759,CYCLE 1 DAY 3 (1),On Trial,,,,,,,,,,6,80,0,,,,0,0,0,30,0,0,0,30,32,15,0,0,0,0,0,0,0,74,3,0,0,77
,,,13,48,Total:,,,,,,,,,,,337,4497,10,,,,92,47,0,152,14,0,0,305,666,2346,0,0,,,,,2573,996,340,67,101,Site 1674
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
